3D Systems Announces Organization Changes and New Executive Leadership Appointments
December 13 2023 - 5:57PM
Today, 3D Systems (NYSE:DDD) announced two additions to its
executive leadership team.
Effective today, December 13, Jeffrey Creech has joined the
company as Executive Vice President and Chief Financial Officer.
Mr. Creech will lead all facets of the company’s global finance
organization.
Effective December 15, Harriss Currie will join the company in
the newly created role of President - Regenerative Medicine. In
this new role, Harriss will lead all elements of 3D Systems’
regenerative medicine efforts, ranging from the company’s
partnership on human organs with United Therapeutics, to its
recently formed Systemic Bio business, which is a wholly-owned
subsidiary of 3D Systems that is focused on bioprinting solutions
for the pharmaceutical industry. The creation of this new role
reflects the increasing maturation of this exciting new technology,
as it moves from early-stage conceptual development toward
commercial application and the value the company believes it will
someday bring to humanity.
Messrs. Creech and Currie will both report to 3D Systems’
President & CEO, Dr. Jeffrey Graves.
Mr. Creech joins 3D Systems with more than 25 years of
experience in financial leadership and business transformation. He
most recently served as Senior Director at the Finely Group, an
executive advisory service company, and prior to that worked as
Chief Operating Officer and Chief Financial Officer for Nutramax
Laboratories, a privately held manufacturer of human and animal
health dietary supplements. Mr. Creech’s career also includes
financial and operations roles with Springs Creative Products Group
where he served as both President and Chief Operating Officer, and
Jefferson Wells where he was the National Director, Business
Transformation COE. He is a Certified Public Accountant and
Certified Management Accountant and holds a bachelor’s degree in
accounting from Pfeiffer University and a master’s degree in
military studies/history from the American Military University.
Mr. Currie will be joining 3D Systems with 30 years of
experience in executive leadership with a focus on building
emerging businesses. He spent more than 20 years with Luminex
Corporation, a DiaSorin Company, that is renowned for its
biological testing technologies for life science applications. As
Senior Vice President and Chief Financial Officer at Luminex,
Harriss helped lead the company’s growth from a start-up to
more than $500 million during his tenure. His career also includes
senior finance leadership roles with Impulse Dynamics and
SpectraCell Laboratories. Harriss earned his bachelor’s degree in
accounting and economics from Southwestern University and his MBA,
with a focus on Marketing and Finance, from the University of Texas
at Austin.
“I’m pleased to welcome Jeffrey and Harriss to 3D Systems in
these very important roles,” said Dr. Jeffrey Graves, president
& CEO, 3D Systems. “Throughout their careers, both have brought
their proven expertise and deep business acumen to bear to drive
sustained customer and shareholder value. Jeffrey’s background and
experience building and leading successful finance teams will be
invaluable to our organization – helping us drive cost efficiencies
to position us for long-term growth. Harriss’s experience in the
biotech industry, combined with his financial and operational
expertise, make him an excellent leader for our emerging
regenerative medicine business, which holds such potential to
benefit our shareholders and all stakeholders in our business. I am
confident that both gentlemen will be integral in our journey as
the leading additive manufacturing solutions provider.”
Dr. Graves continued, “I also wish to extend my heartfelt thanks
to Andy Johnson who served as Interim CFO while we executed this
search. Andy is a key member of our leadership team as Chief
Corporate Development Officer and Chief Legal Officer. I am
grateful that he seamlessly added the role of CFO to his plate. His
leadership has been instrumental in this transition period.”
Forward-Looking StatementsCertain statements
made in this release that are not statements of historical or
current facts are forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995.
Forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results,
performance or achievements of the company to be materially
different from historical results or from any future results or
projections expressed or implied by such forward-looking
statements. In many cases, forward-looking statements can be
identified by terms such as “believes,”
“belief,” “expects,” “may,” “will,” “estimates,” “intends,” “anticipates” or
“plans” or the negative of these terms or other comparable
terminology. Forward-looking statements are based upon management’s
beliefs, assumptions, and current expectations and may include
comments as to the company’s beliefs and expectations as to future
events and trends affecting its business and are necessarily
subject to uncertainties, many of which are outside the control of
the company. The factors described under the headings
“Forward-Looking Statements” and “Risk Factors” in the
company’s periodic filings with the Securities and Exchange
Commission, as well as other factors, could cause actual results to
differ materially from those reflected or predicted in
forward-looking statements. Although management believes that the
expectations reflected in the forward-looking statements are
reasonable, forward-looking statements are not, and should not be
relied upon as a guarantee of future performance or results, nor
will they necessarily prove to be accurate indications of the times
at which such performance or results will be achieved. The
forward-looking statements included are made only as of the date of
the statement. 3D Systems undertakes no obligation to update or
review any forward-looking statements made by management or on its
behalf, whether as a result of future developments, subsequent
events or circumstances or otherwise, except as required by
law.
About 3D Systems More than 35 years ago, 3D
Systems brought the innovation of 3D printing to the manufacturing
industry. Today, as the leading additive manufacturing solutions
partner, we bring innovation, performance, and reliability to every
interaction - empowering our customers to create products and
business models never before possible. Thanks to our unique
offering of hardware, software, materials, and services, each
application-specific solution is powered by the expertise of our
application engineers who collaborate with customers to transform
how they deliver their products and services. 3D Systems’ solutions
address a variety of advanced applications in healthcare and
industrial markets such as medical and dental, aerospace &
defense, automotive, and durable goods. More information on the
company is available at www.3dsystems.com.
Investor
Contact: |
investor.relations@3dsystems.com |
Media Contact: |
press@3dsystems.com |
|
|
Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/6560dbbb-64ec-4458-9dc1-a702529108d2
https://www.globenewswire.com/NewsRoom/AttachmentNg/f47a7b9a-2354-46fb-96ef-0608fadc499c
3D Systems (NYSE:DDD)
Historical Stock Chart
From Mar 2024 to Apr 2024
3D Systems (NYSE:DDD)
Historical Stock Chart
From Apr 2023 to Apr 2024